Experimental evidence demonstrates that PGC1, a key transcription factor that is regulated by MYC which drives mitochondrial biogenesis and fission, is highly expressed and is poor prognostic marker in numerous cancer types; increasing OXPHOS and establishing drug resistance [206, 279]. Here, PPARGC1A is linked to cancer.